Shana Rosal Greif, MD
Cardiovascular Disease (Cardiology) · Charlotte
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · The Presbyterian Hospital · Novant Health Medical Group, LLC · Novant Health Matthews Medical Center LLC
Hospitals listed: Novant Health Huntersville Medical Center · Novant Health Presbyterian Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Greif’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Novant Health Huntersville Medical CenterHuntersville, NCAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Novant Health, which runs 13 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.172, Oct 2024 – Sep 2025
- Novant Health Presbyterian Medical CenterCharlotte, NCAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Novant Health, which runs 13 hospitalsPatients rate it 2 of 5 · 69% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.69 (0.43 to 0.94), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.231, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.154, Oct 2024 – Sep 2025
See every measure and the patient survey for Novant Health Huntersville Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 5 the same, 1 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.172 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.82 (0 to 1.78) · 639 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.5 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.48 (118.64 to 236.33) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.4 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 186 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 2,199 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,715 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,778 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.08 (1.82 to 6.35) · 697 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.44 to 3.72) · 676 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.84 (0 to 15.87) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.01 (2.02 to 10) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.1) · 173 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.26 (0 to 1.11) · 3,086 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 97 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.309 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.065 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.526 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.589 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 145 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 512 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -28.1 · 95 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.3 · 355 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -16.3 · 350 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.7 · 515 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.5 (8.8 to 15) · 962 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 549 cases | No different | Jan 2024 – Dec 2024 |
What patients said (369 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Novant Health Presbyterian Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.69 (0.43 to 0.94) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.231 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.154 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0.01 to 1.8) · 1,589 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 142.65 (99.01 to 186.29) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.6 · 147 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 277 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 475 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 4,537 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 7,489 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 7,979 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.99 (2.38 to 5.6) · 3,504 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.49 (0.19 to 2.8) · 2,311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.58 (1.33 to 3.82) · 3,221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.85 (1.36 to 10.33) · 2,188 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.18 (0.28 to 6.08) · 2,233 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 598 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 6,065 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 526 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.792 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.635 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.683 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.148 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 376 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 623 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.4 · 218 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.2 · 348 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.2 · 285 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 559 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4.3 to 6.9) · 646 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (9.6 to 13.6) · 646 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.6 · 519 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.7 · 223 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.7 to 16.8) · 831 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (349 patients answered, 16% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$81,549
Medicare paid this office $81,549 for 396 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of pacemaker and upper and lower heart chamber electrode | 23 | $7,970 | $347 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $7,399 | $673 |
| Insertion of implantable defibrillator system | 11 | $7,189 | $654 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,408 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $4,943 | $88 |
See all 21 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 23 | $7,970 | $347 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $7,399 | $673 |
| Insertion of implantable defibrillator system | 11 | $7,189 | $654 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,408 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $4,943 | $88 |
| Long return visit (40+ min) | 44 | $4,620 | $98 |
| Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm | 22 | $4,278 | $194 |
| Long return visit (40+ min) | 24 | $3,714 | $133 |
| New patient visit (60+ min) | 26 | $3,108 | $120 |
| New patient visit (60+ min) | 19 | $3,043 | $160 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 48 | $1,773 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 33 | $1,637 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 120 | $1,120 | $6 |
| Return visit (30+ min) | 15 | $1,088 | $64 |
| Return visit (30+ min) | 11 | $1,054 | $96 |
| Programming of dual lead pacemaker system | 25 | $974 | $34 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $628 | $48 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $624 | $26 |
| Short return visit (20+ min) | 11 | $590 | $49 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $304 | $9 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 14 | $241 | $17 |
Procedures Medicare counted
| Pacemaker insertion or repair | 25 | More than 75% of doctors who do this |
Who their Medicare patients are
396 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 20% · Women 44% · Also on Medicaid 10% · Health risk score 2.05. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 59% · Coronary heart disease 56% · Heart failure 47% · Chronic kidney disease 46% · Diabetes 37% · Depression 30% · Cancer 24% · COPD 22% · Stroke 19% · Dementia 14%.
The office billed $335,748, Medicare allowed $104,207 and paid $81,549; for 946 services of 63 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 396 | 946 | 76 | 2.05 | $335,748 | $81,549 |
| 2023 | 88 | 160 | 76 | 1.47 | $72,646 | $18,674 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $3,560 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,899 | $90 |
| Long return visit (40+ min) | 15 | $1,629 | $109 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $141 | $9 |
Medicaid work
$57 in 2024
Medicaid paid $57 for 23 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 23 | $57 |
| 2024 | 23 | 1 | 14 | $57 |
Drugs they prescribed that Part D paid
$52,185
Pharmacies billed $52,185 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
339 generic and 79 brand-name prescriptions · $52,185 in drug cost · 14 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $44,039 | $864 |
| Metoprolol | 47 | $1,959 | $16 |
| Amiodarone | 14 | $1,161 | $50 |
| Sucralfate | 23 | $332 | $14 |
| Diltiazem 24hr Er (Cd) | 11 | $248 | $11 |
See all 7 drugs
| Eliquis | 11 | $44,039 | $864 |
| Metoprolol | 47 | $1,959 | $16 |
| Amiodarone | 14 | $1,161 | $50 |
| Sucralfate | 23 | $332 | $14 |
| Diltiazem 24hr Er (Cd) | 11 | $248 | $11 |
| Metoprolol | 25 | $228 | $4 |
| Pantoprazole | 21 | $205 | $8 |
Year by year
| 2024 | 418 | 132 | None | 19% | $52,185 |
| 2023 | 24 | 20 | 0% (0) | None | $1,239 |
| 2022 | 17 | None | None | None | $3,370 |
| 2021 | 65 | 22 | 0% (0) | None | $10,207 |
| 2020 | 58 | 21 | None | None | $11,200 |
| 2019 | 40 | 18 | None | None | $9,035 |
| 2018 | 136 | 40 | None | 44% | $9,091 |
| 2017 | 329 | 101 | 6% (20) | 29% | $15,664 |
| 2016 | 282 | 70 | None | 31% | $14,168 |
| 2015 | 47 | 17 | 0% (0) | None | $4,581 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Metoprolol | 18 | $602 | $33 |
2020: 1 drug
| Metoprolol | 14 | $304 | $22 |
2018: 2 drugs
| Atorvastatin | 25 | $827 | $33 |
| Furosemide | 11 | $135 | $12 |
2017: 8 drugs
| Atorvastatin | 34 | $1,148 | $34 |
| Furosemide | 35 | $406 | $12 |
| Clopidogrel | 15 | $405 | $27 |
| Bisoprolol | 13 | $294 | $23 |
| Lisinopril | 21 | $245 | $12 |
| Omeprazole | 13 | $234 | $18 |
| Carvedilol | 16 | $140 | $9 |
| Metoprolol | 13 | $127 | $10 |
2016: 6 drugs
| Atorvastatin | 39 | $1,343 | $34 |
| Clopidogrel | 16 | $564 | $35 |
| Lisinopril | 18 | $210 | $12 |
| Spironolactone | 12 | $206 | $17 |
| Metoprolol | 20 | $171 | $9 |
| Furosemide | 13 | $143 | $11 |
Money from drug and device companies
$1,758 in 2025
| 2025 | 11 | 52 | None | $1,758 |
| 2024 | 12 | 48 | None | $1,265 |
| 2023 | 14 | 52 | None | $7,615 |
| 2022 | 3 | 14 | None | $11,882 |
| 2021 | 3 | 5 | None | $9,055 |
| 2020 | 1 | 5 | None | $1,687 |
| 2019 | 2 | 2 | None | $115 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Watchman Flx | $661 | 17 payments
|
| Biosense Webster | Carto 3 | $638 | 12 payments
|
| Abbott Laboratories | Ensite | $217 | 12 payments
|
| Medtronic | Pulseselect | $64 | 3 payments
|
| Scpharmaceuticals | Furoscix | $47 | 2 payments
|
| Davol | None | $38 | 1 payment
|
See all 52 published payments
| Abbott Laboratories | Meals · 2025-12-31 | Ensite | $20 |
| BridgeBio Pharma | Meals · 2025-12-31 | Attruby | $21 |
| Boston Scientific | Meals · 2025-12-09 | Watchman Access System | $38 |
| Abbott Laboratories | Meals · 2025-12-03 | Gallant | $26 |
| Davol | Meals · 2025-11-24 | None | $38 |
| Medtronic | Meals · 2025-11-13 | Aurora Ev-Icd Mri Surescan | $23 |
| Boston Scientific | Meals · 2025-11-11 | Watchman Access System | $38 |
| Abbott Laboratories | Meals · 2025-11-09 | Jot Dx | $18 |
| Boston Scientific | Meals · 2025-11-07 | Farapulse | $49 |
| Boston Scientific | Meals · 2025-11-05 | Watchman Flx | $53 |
| Scpharmaceuticals | Meals · 2025-11-05 | Furoscix | $18 |
| Abbott Laboratories | Meals · 2025-10-28 | Ensite | $21 |
| Boston Scientific | Meals · 2025-10-27 | General - Therapies | $37 |
| Biosense Webster | Meals · 2025-10-21 | Carto 3 | $69 |
| Novo Nordisk | Meals · 2025-10-21 | Wegovy | $14 |
| Boston Scientific | Meals · 2025-10-02 | General - Crm Crm | $18 |
| Cardiva Medical | Meals · 2025-09-15 | Cardiva Vascade Mvp Vvcs 6-12f | $19 |
| Scpharmaceuticals | Meals · 2025-09-15 | Furoscix | $29 |
| Boston Scientific | Meals · 2025-09-09 | Watchman Flx | $48 |
| Abiomed | Meals · 2025-08-26 | None | $26 |
| Boston Scientific | Meals · 2025-07-29 | Watchman Flx | $37 |
| Abbott Laboratories | Meals · 2025-06-27 | Perclose Prostyle | $18 |
| Abbott Laboratories | Meals · 2025-06-24 | Gallant | $9 |
| Biosense Webster | Meals · 2025-06-10 | Carto 3 | $33 |
| Biosense Webster | Meals · 2025-06-10 | Carto 3 | $10 |
| Biosense Webster | Meals · 2025-05-23 | Carto 3 | $13 |
| Boston Scientific | Meals · 2025-05-13 | Watchman Access System | $24 |
| Boston Scientific | Meals · 2025-05-09 | Watchman Access System | $25 |
| Biosense Webster | Meals · 2025-05-07 | Carto 3 | $43 |
| Biosense Webster | Meals · 2025-05-07 | Carto 3 | $180 |
| Boston Scientific | Meals · 2025-05-05 | Watchman Flx | $155 |
| Biosense Webster | Meals · 2025-04-29 | Carto 3 | $143 |
| Boston Scientific | Meals · 2025-04-29 | Watchman Access System | $25 |
| Abbott Laboratories | Meals · 2025-04-28 | Ensite | $22 |
| Biosense Webster | Meals · 2025-04-18 | Carto 3 | $17 |
| Abbott Laboratories | Meals · 2025-04-08 | Assurity | $23 |
| Biosense Webster | Meals · 2025-03-27 | Carto 3 | $55 |
| Abbott Laboratories | Meals · 2025-03-26 | Gallant | $12 |
| Boston Scientific | Meals · 2025-03-24 | Watchman Flx | $25 |
| Boston Scientific | Meals · 2025-03-19 | Watchman Access System | $22 |
| Abbott Laboratories | Meals · 2025-02-28 | Ensite | $20 |
| Boston Scientific | Meals · 2025-02-26 | Watchman Flx | $29 |
| Boston Scientific | Meals · 2025-02-25 | Farapulse | $24 |
| Boston Scientific | Meals · 2025-02-20 | Farapulse | $15 |
| Medtronic | Meals · 2025-02-14 | Micra | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-02-11 | Lifevest | $14 |
| Biosense Webster | Meals · 2025-02-07 | Carto 3 | $13 |
| Medtronic | Meals · 2025-02-06 | Pulseselect | $25 |
| Abbott Laboratories | Meals · 2025-02-03 | Ensite | $22 |
| Biosense Webster | Meals · 2025-01-17 | Carto 3 | $28 |
| Biosense Webster | Meals · 2025-01-13 | Carto 3 | $34 |
| Abbott Laboratories | Meals · 2025-01-06 | Agilis Hispro | $6 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,265
| Boston Scientific | Watchman Flx | $416 | 5 payments
|
| Biosense Webster | Carto 3 | $309 | 16 payments
|
| Abbott Laboratories | Ensite | $200 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $84 | 4 payments
|
| Medtronic | Linq II | $77 | 3 payments
|
| Elutia | Ecm Patch,Pouch | $45 | 2 payments
|
| iRhythm Technologies | Zio Monitor | $29 | 2 payments
|
| Scpharmaceuticals | Furoscix | $24 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| Novo Nordisk | None | $20 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $19 | 1 payment
|
| Amgen | Repatha | $18 | 1 payment
|
2023: $7,615
| Biotronik | Sentus | $2,637 | 10 payments
|
| Boston Scientific | Rhythmia Mapping System | $2,108 | 7 payments
|
| Medtronic | Selectsecure | $1,910 | 7 payments
|
| Abbott Laboratories | Na | $534 | 12 payments
|
| Biosense Webster | Carto 3 | $231 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $34 | 2 payments
|
| Scpharmaceuticals | Furoscix | $24 | 1 payment
|
| Amgen | Repatha | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Wainua | $22 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $21 | 1 payment
|
| Aziyo Biologics | Ecm Patch,Pouch | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $16 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $14 | 1 payment
|
2022: $11,882
| Boston Scientific | Emblem Mri S-Icd | $6,102 | 7 payments
|
| Medtronic | None | $5,260 | 2 payments
|
| Biotronik | Biomonitor | $520 | 5 payments
|
2021: $9,055
| Medtronic | Micra | $5,201 | 3 payments
|
| Boston Scientific | Emblem | $3,750 | 1 payment
|
| Biotronik | Rivacor | $105 | 1 payment
|
2020: $1,687
| Boston Scientific | General - Therapies | $1,687 | 5 payments
|
2019: $115
| E.R. Squibb & Sons L.L.C. | Eliquis | $96 | 1 payment
|
| Boston Scientific | Radia | $19 | 1 payment
|
Professional record
- NPI
- 1447644885
- Licence
- NC 2023-01644
- Group
- The Presbyterian Hospital · Novant Health Medical Group, LLC · Novant Health Matthews Medical Center LLC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- Po Box 60447, Charlotte, NC, 28260
- NPI first listed
- 2015-03-24
- NPI last updated
- 2023-09-05
- NPI record certified
- 2023-09-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305